SCHEMBL21780346

SCHEMBL21780346

CCC(N)(CN)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8531420 0.84 MEN1 (0.60)
SCHEMBL45629 0.84
SCHEMBL8365 0.84
Ammonia Solution, Strong SCHEMBL8339371 0.81
Hydroxyamine SCHEMBL2673839 0.81 MEN1 (0.32)
Bromide SCHEMBL1472016 0.81
Tromethamine SCHEMBL11647748 0.81 MEN1 (0.67)
Hydrochloric Acid SCHEMBL1469923 0.81
Alcohol SCHEMBL18575663 0.81 MEN1 (0.56)
Ammonia Solution, Strong SCHEMBL15322546 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3097098-B1 PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE HOFFMANN LA ROCHE (CH) 2020-03-04 EP disclosed